{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:47:42Z","timestamp":1782298062887,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/ejhg.2008.263","type":"journal-article","created":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T11:26:32Z","timestamp":1233141992000},"page":"938-945","source":"Crossref","is-referenced-by-count":30,"title":["The complex interaction between APOE promoter and AD: an Italian case\u2013control study"],"prefix":"10.1038","volume":"17","author":[{"given":"Alessandra","family":"Bizzarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Seripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Acciarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Danilo","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Masullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"BFejhg2008263_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.crvi.2004.10.013","volume":"328","author":"PH St George-Hyslop","year":"2005","unstructured":"St George-Hyslop PH, Petit A : Molecular biology and genetics of Alzheimer's disease. C R Biol 2005; 328: 119\u2013130.","journal-title":"C R Biol"},{"key":"BFejhg2008263_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1515\/REVNEURO.2005.16.4.325","volume":"16","author":"NH Zawia","year":"2005","unstructured":"Zawia NH, Basha MR : Environmental risk factors and the developmental basis for Alzheimer's disease. Rev Neurosci 2005; 16: 325\u2013337.","journal-title":"Rev Neurosci"},{"key":"BFejhg2008263_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jama.1995.03530200063039","volume":"274","author":"American College of Medical Genetics\/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease","year":"1995","unstructured":"American College of Medical Genetics\/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease: Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995; 274: 1627\u20131629.","journal-title":"JAMA"},{"key":"BFejhg2008263_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0140-6736(96)90284-6","volume":"347","author":"National Institute on Aging\/Alzheimer's Association Working Group","year":"1996","unstructured":"National Institute on Aging\/Alzheimer's Association Working Group: Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091\u20131095.","journal-title":"Lancet"},{"key":"BFejhg2008263_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-5793(97)01543-3","volume":"421","author":"MJ Artiga","year":"1998","unstructured":"Artiga MJ, Bullido MJ, Sastre I et al: Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 1998; 421: 105\u2013108.","journal-title":"FEBS Lett"},{"key":"BFejhg2008263_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/1097-0029(20000815)50:4<261::AID-JEMT2>3.0.CO;2-B","volume":"50","author":"MJ Bullido","year":"2000","unstructured":"Bullido MJ, Valdivieso F : Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Microsc Res Tech 2000; 50: 261\u2013267.","journal-title":"Microsc Res Tech"},{"key":"BFejhg2008263_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0304-3940(01)01790-6","volume":"304","author":"A Alvarez-Arcaya","year":"2001","unstructured":"Alvarez-Arcaya A, Combarros O, Llorca J, Sanchez-Guerra M, Berciano J, Fernandez-Luna JL : The \u2212491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease. Neurosci Lett 2001; 304: 204\u2013208.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR8","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/hmg\/ddh299","volume":"13","author":"NJ Bray","year":"2004","unstructured":"Bray NJ, Jehu L, Moskvina V et al: Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum Mol Genet 2004; 13: 2885\u20132892.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2008263_CR9","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/hmg\/7.9.1511","volume":"7","author":"JC Lambert","year":"1998","unstructured":"Lambert JC, Berr C, Pasquier F et al: Pronounced impact of Th1\/E47cs mutation compared with \u2212491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998; 7: 1511\u20131516.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2008263_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1046\/j.1471-4159.2003.01615.x","volume":"84","author":"SM Laws","year":"2003","unstructured":"Laws SM, Hone E, Gandy S, Martins RN : Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003; 84: 1215\u20131236.","journal-title":"J Neurochem"},{"key":"BFejhg2008263_CR11","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/hmg\/7.12.1887","volume":"7","author":"MJ Artiga","year":"1998","unstructured":"Artiga MJ, Bullido MJ, Frank A et al: Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum Mol Genet 1998; 7: 1887\u20131892.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2008263_CR12","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1212\/WNL.53.8.1888","volume":"53","author":"VM Casadei","year":"1999","unstructured":"Casadei VM, Ferri C, Veglia F et al: APOE \u2212491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology 1999; 53: 1888\u20131889.","journal-title":"Neurology"},{"key":"BFejhg2008263_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1212\/WNL.55.11.1644","volume":"55","author":"JC Wang","year":"2000","unstructured":"Wang JC, Kwon JM, Shah P, Morris JC, Goate A : Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology 2000; 55: 1644\u20131649.","journal-title":"Neurology"},{"key":"BFejhg2008263_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/01.pdm.0000213451.99655.1d","volume":"15","author":"D Seripa","year":"2006","unstructured":"Seripa D, Signori E, Gravina C, Matera MG, Rinaldi M, Fazio VM : Simple and effective determination of apolipoprotein E genotypes by positive\/negative polymerase chain reaction products. Diagn Mol Path 2006; 15: 180\u2013185.","journal-title":"Diagn Mol Path"},{"key":"BFejhg2008263_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gepi.1370090302","volume":"9","author":"LA Gerdes","year":"1992","unstructured":"Gerdes LA, Klausen IB, Sihm I, F\u00e6rgeman O : Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992; 9: 155\u2013167.","journal-title":"Genet Epidemiol"},{"key":"BFejhg2008263_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/1097-0142(19930115)71:2<510::AID-CNCR2820710236>3.0.CO;2-N","volume":"71","author":"G Leandro","year":"1993","unstructured":"Leandro G, Duca P : The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area: a case\u2013control study. Cancer 1993; 71: 510\u2013511.","journal-title":"Cancer"},{"key":"BFejhg2008263_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith N, Donnelly P : A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978\u2013989.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2008263_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/379378","volume":"73","author":"M Stephens","year":"2003","unstructured":"Stephens M, Donnelly P : A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162\u20131169.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2008263_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1469-1809.2006.00344.x","volume":"71","author":"D Seripa","year":"2007","unstructured":"Seripa D, Matera MG, Daniele A et al: The missing ApoE allele. Ann Hum Genet 2007; 71: 496\u2013500.","journal-title":"Ann Hum Genet"},{"key":"BFejhg2008263_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0304-3940(99)00126-3","volume":"263","author":"ARH Ahmed","year":"1999","unstructured":"Ahmed ARH, MacGowan SH, Culpan D, Jones RW, Wilcock GK : The \u2212491 A\/T polymorphism of the apolipoprotein E gene is associated with the ApoEe4 allele and Alzheimer's disease. Neurosci Lett 1999; 263: 217\u2013219.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(00)04063-0","volume":"357","author":"JC Lambert","year":"2001","unstructured":"Lambert JC, Mann D, Goumidi L et al: Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet 2001; 357: 608\u2013609.","journal-title":"Lancet"},{"key":"BFejhg2008263_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/hmg\/7.3.533","volume":"7","author":"JC Lambert","year":"1998","unstructured":"Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC : A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998; 7: 533\u2013540.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2008263_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10048-004-0189-9","volume":"5","author":"KK Nicodemus","year":"2004","unstructured":"Nicodemus KK, Stenger JE, Schmechel DE et al: Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease. Neurogenetics 2004; 5: 201\u2013208.","journal-title":"Neurogenetics"},{"key":"BFejhg2008263_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ajmg.10407","volume":"114","author":"G Roks","year":"2002","unstructured":"Roks G, Cruts M, Houwing-Duistermaat JJ et al: Effect of the APOE \u2212491A\/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: the Rotterdam Study. Am J Med Genet 2002; 114: 570\u2013573.","journal-title":"Am J Med Genet"},{"key":"BFejhg2008263_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(03)00815-2","volume":"350","author":"JD Yang","year":"2003","unstructured":"Yang JD, Feng GY, Zhang J, Cheung J, St Clair D, He L : Apolipoprotein E \u2212491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population. Neurosci Lett 2003; 350: 25\u201328.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/WNL.59.1.59","volume":"59","author":"JC Lambert","year":"2002","unstructured":"Lambert JC, Araria-Goumidi L, Myllykangas L et al: Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002; 59: 59\u201366.","journal-title":"Neurology"},{"key":"BFejhg2008263_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s004150050461","volume":"246","author":"S Helisalmi","year":"1999","unstructured":"Helisalmi S, Hiltunen M, Valonen P et al: Promoter polymorphism (\u2212491 A\/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. J Neurol 1999; 246: 821\u2013824.","journal-title":"J Neurol"},{"key":"BFejhg2008263_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3940(98)00470-4","volume":"250","author":"YQ Song","year":"1998","unstructured":"Song YQ, Rogaeva E, Premkumar S et al: Absence of association between Alzheimer disease and the \u2212491 regulatory region polymorphism of APOE. Neuroscience Lett 1998; 250: 189\u2013192.","journal-title":"Neuroscience Lett"},{"key":"BFejhg2008263_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0304-3940(98)00855-6","volume":"259","author":"H Toji","year":"1999","unstructured":"Toji H, Maruyama H, Sasaki K, Nakamura S, Kawakami H : Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci Lett 1999; 259: 56\u201358.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/sj.mp.4001097","volume":"7","author":"SM Laws","year":"2002","unstructured":"Laws SM, Hone E, Taddei K et al: Variation at the APOE \u2212491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol Psychiatry 2002; 7: 886\u2013890.","journal-title":"Mol Psychiatry"},{"key":"BFejhg2008263_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00001756-199903170-00038","volume":"10","author":"SM Laws","year":"1999","unstructured":"Laws SM, Taddei K, Martins G et al: The \u2212491 AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport 1999; 10: 879\u2013882.","journal-title":"Neuroreport"},{"key":"BFejhg2008263_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-002-0602-0","volume":"105","author":"J Pahnke","year":"2003","unstructured":"Pahnke J, Walker LC, Schroeder E et al: Cerebral beta-amyloid deposition is augmented by the \u2013491 AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E \u025b4 allele. Acta Neuropathol 2003; 105: 25\u201329.","journal-title":"Acta Neuropathol"},{"key":"BFejhg2008263_CR33","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T et al: Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 2892\u20132897.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2008263_CR34","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"DM Holtzman","year":"1999","unstructured":"Holtzman DM, Bales KR, Wu S et al: Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest 1999; 103: R15\u2013R21.","journal-title":"J Clin Invest"},{"key":"BFejhg2008263_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200513","volume":"8","author":"L Zurutuza","year":"2000","unstructured":"Zurutuza L, Verpillat P, Raux G et al: APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur J Hum Genet 2000; 8: 713\u2013716.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2008263_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ajmg.10202","volume":"114","author":"L Myllykangas","year":"2002","unstructured":"Myllykangas L, Polvikoski T, Reunanen K et al: ApoE e3-haplotype modulates Alzheimer beta-amyloid deposition in the brain. Am J Med Genet 2002; 114: 288\u2013291.","journal-title":"Am J Med Genet"},{"key":"BFejhg2008263_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ajmg.10142","volume":"107","author":"BT Heijmans","year":"2002","unstructured":"Heijmans BT, Slagboom PE, Gussekloo J et al: Association of APOE varepsilon2\/varepsilon3\/varepsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet 2002; 107: 201\u2013208.","journal-title":"Am J Med Genet"},{"key":"BFejhg2008263_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2004.04.063","volume":"365","author":"JC Lambert","year":"2004","unstructured":"Lambert JC, Berr C, Cottel D, Amouyel P, Helbecque N : APOE promoter polymorphisms and dementia in the elderly. Neurosci Lett 2004; 365: 116\u2013119.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3940(98)00567-9","volume":"252","author":"T Town","year":"1998","unstructured":"Town T, Paris D, Fallin D et al: The \u2013491A\/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci Lett 1998; 252: 95\u201398.","journal-title":"Neurosci Lett"},{"key":"BFejhg2008263_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0304-3940(03)00816-4","volume":"349","author":"G Parra-Bonilla","year":"2003","unstructured":"Parra-Bonilla G, Arboleda G, Yunis J et al: Haplogroup analysis of the risk associated with APOE promoter polymorphism (\u2212219T\/G, \u2212491A\/T and \u2013427T\/C) in Colombian Alzheimer's disease patients. Neurosci Lett 2003; 349: 159\u2013162.","journal-title":"Neurosci Lett"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008263","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:56:27Z","timestamp":1684428987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2008263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFejhg2008263"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2008.263","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}